Biosimilars in Pediatric Inflammatory Bowel Diseases: A Systematic Review and Real Life-Based Evidence

Background: Many pediatric inflammatory bowel disease (IBD) patients are now using biosimilars of anti-tumor necrosis factor-α (TNF-α), with increasing trends in recent years. This study reviewed all available data regarding the use of biosimilars in children with IBD. Methods: PubMed, Google Schola...

Descripción completa

Detalles Bibliográficos
Autores principales: Dipasquale, Valeria, Cicala, Giuseppe, Spina, Edoardo, Romano, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970685/
https://www.ncbi.nlm.nih.gov/pubmed/35370732
http://dx.doi.org/10.3389/fphar.2022.846151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970685/
https://www.ncbi.nlm.nih.gov/pubmed/35370732
http://dx.doi.org/10.3389/fphar.2022.846151

Ejemplares similares